Defining the complex needs of families with rare diseases-the example of telomere biology disorders

Catherine Wilsnack1, Camella J Rising2, Emily E Pearce2

  • 1Steve Hicks School of Social Work, University of Texas at Austin, Austin, TX, USA.

Insights

Families managing rare telomere biology disorders (TBDs) face significant unmet needs across medical, psychosocial, and financial areas. Addressing these requires coordinated, multi-disciplinary interventions for patients and caregivers.

Area of Science:

  • Rare disease research
  • Genetics and inherited disorders
  • Patient and family support

Background:

  • Telomere biology disorders (TBDs) are rare inherited syndromes.
  • TBDs present significant health challenges, including bone marrow failure, cancer, and pulmonary fibrosis.
  • Families affected by TBDs experience extensive unmet needs due to disease complexity and severity.

Purpose of the Study:

  • To identify and understand the unmet needs of adults with TBDs and their family caregivers.
  • To pinpoint gaps in clinical care for individuals and families affected by TBDs.
  • To provide a foundation for improving care for rare diseases.

Main Methods:

  • A mixed-methods approach combining online surveys (N=35) and semi-structured telephone interviews (N=32).
  • Participants included adults with self-reported TBDs and/or family caregivers (current or bereaved).
  • Quantitative data analyzed using descriptive statistics; qualitative data underwent thematic analysis.

Main Results:

  • Participants reported numerous unmet needs in psychosocial, medical, financial, and daily activity domains.
  • Both survey and interview data highlighted critical shortfalls in managing chronic family distress and coordinating specialty care.
  • Adults and caregivers of individuals with TBDs are at high risk for adverse psychosocial outcomes.

Conclusions:

  • Families affected by TBDs have substantial unmet needs requiring targeted support.
  • There are critical gaps in addressing chronic family distress and care coordination for rare diseases.
  • Multi-disciplinary interventions involving patients, families, clinicians, and advocacy groups are essential to meet the needs of rare disease patients.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.2K
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.6K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Karyotyping01:17

Karyotyping

Overview
59.1K
Pedigree Analysis01:35

Pedigree Analysis

Overview
84.1K
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.6K